ARCHIVES

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 42 | November 1, 1991

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products.

July 9, 2004

Congress Urges CMS To Soften Proposal For Coverage Of ESAs in Oncology.

July 20, 2007

Non-Caucasians At Higher Risk For Severe Breast Cancer Pain

December 28, 2007

Health Groups Urge FDA To Regulate Tobacco Products, Including E-Cigarettes

September 5, 2014

Soybean Studies, Computing Support Recompetition Ok’d

November 9, 1990

Comprehensive Center NCAB Evaluations

June 2, 1978